Publication Search

The increasing trend in skincare usage, particularly whitening products, has led many business actors to market their products extensively without regard for legal compliance. One notable issue is the circulation of blue-label skincare products, which should only be provided with a doctor's prescription. The research employs a normative juridical method with a qualitative approach, utilizing interviews and literature study. The findings reveal that legal protection for consumers in the use of blue-label skincare products remains suboptimal. These products often contain active ingredients such as corticosteroids or antibiotics, which should only be used under a doctor's prescription and supervision. However, in practice, many business actors continue to sell them freely via online marketplaces and social media platforms. This not only violates BPOM regulations and health laws but also poses a direct threat to consumer safety. Furthermore, business accountability is still lacking, as evidenced by the insufficient transparency regarding product content, usage instructions, and distribution permits.

Bell’s Palsy is an acute peripheral facial nerve paralysis that causes unilateral facial weakness. The exact cause remains unclear but is suspected to involve anatomical factors, infections, viral reactivation (especially Herpes Simplex Virus), ischemia, inflammation, and cold exposure. The incidence is 20-30 per 100,000 people annually, with no gender or age preference, though it is more common in middle-aged and elderly individuals. Risk factors include diabetes, pregnancy, preeclampsia, obesity, and hypertension. Symptoms develop suddenly, peaking within 48 hours, and include facial asymmetry, difficulty closing the eyes, eating, speaking, and sensory-motor disturbances. Most cases recover spontaneously within weeks to months, but corticosteroids and antiviral therapy can accelerate recovery. Proper diagnosis is crucial as Bell’s Palsy is often mistaken for stroke or other neurological disorders.

Dermatitis is an inflammatory skin disease that is accompanied by itchy skin. It occurs in infants, and gets better in adolescence, but some cases can persist for a long time or even develop the disease in adulthood. In general, if you have this skin disease, you should see a skin specialist for a consultation. However, skin specialists are not always at the hospital, making it difficult for patients to arrange appointments to meet or consult. Therefore, the hospital needs to have an additional system that can help facilitate the medical team to detect the type of dermatitis disease based on symptoms (blistering skin, redness of the skin, scaly and dry skin, dark skin, blistering skin, cracked skin that is present in the disease, atopic dermatitis, contact dermatitis, seberoic dermatitis, nummular dermatitis, and intertriginous dermatitis and get handling and understanding of dermatitis disease using the certainty factor method. From the analysis carried out, the results of the diagnosis of the selected symptoms are obtained, the most accurate diagnosis is Atopic Dermatitis 98% with the treatment given, namely Corticosteroids and Antihistamines to patients.  

Generalized exfoliative dermatitis, also known as erythroderma, is a skin disease with dermatological features in the form of diffuse erythema and scaling that affects more than 90% of the skin surface. This report describes the case of a 65 year old man who came with the main complaint, the skin all over his body felt itchy and peeling since approximately 2 years ago. The itching experienced by the patient worsens during hot weather/temperature, usually occurring during the day and night, but the itching experienced is more severe at night. The patient's complaints began with the appearance of redness on the skin in the left and right hand area, then spread to the chest area, groin/genital area, both legs, and throughout the body up to the head. Dermatological status examination revealed diffuse erythema macules accompanied by rough scales all over the body. The patient was diagnosed with generalized exfoliative dermatitis. In management, patients are given education to maintain skin moisture, avoid scratching the skin, and consume foods high in protein such as red meat. The pharmacological management given is in the form of corticosteroid drugs, antibiotics, proton pump inhibitors, antihistamines, and several topical drugs to reduce complaints of itching and peeling skin in patients.

Amyloidosis is a term for various groups of diseases with lots of amyloid protein in organs and/or tissues, causing disease. In this condition, amyloid protein is deposited in the dermis layer of the skin which is called lichen amyloidosis. Lichen amyloidosis is the most common type of cutaneous amyloidosis. The prevalence of cutaneous amyloidosis is relatively rare, only 0.2-0.3%. It is chronic in nature which usually appears later in life. This article discusses a case of a 39-year-old female patient who came with complaints of spots on both sides accompanied by itching. These complaints have been experienced since ± 2 years ago and are felt to be getting worse in the last few months. Previously the patient had used a type of topical medication obtained from the local puskesmas, but there was no improvement. Examination of the general status found the general condition of the patient looked moderately ill, conscious awareness, vital signs within normal limits. Dermatological status obtained efflorescence in the form of macules to multiple papules with hyperpigmentation, well defined, discrete available, accompanied by scaling and lichenification. Patients were treated with oral corticosteroids (methylprednisolone), topical corticosteroids (desoximethasone) and salicylic acid. Patients are also educated to avoid scratching and rubbing on the lesions. The patient showed thinning lesions after 7 days of therapy.